Moreover, Ibarretxe et al. suggested that FABP5 was associated with increased subclinical atherosclerosis and higher FABP5 plasma levels was associated with the presence of type 2 diabetes, obesity, metabolic syndrome, or atherogenic dyslipidemia [27]. Here, FABP5 is linked to atherosclerosis.